HLA-W: A Key MHC Component in The Immune Response (G352966)
HLA-W: A Key MHC Component in The Immune Response
The Major Histocompatibility Complex (MHC) is a critical immune system component that plays a crucial role in the immune response against viruses, bacteria, and other pathogens. The MHC is a protein complex that consists of six classes of molecules: MHC I, MHC II , MHC III, MHC IV, MHC V, and MHC VI. MHC I and MHC II are the most well-studied and are also known as the major histocompatibility complex (MHC).
MHC I and MHC II are responsible for presenting antigens from the body's own cells to the immune system. These molecules contain a unique set of genes that encode antigens that are specific to self-cells, but not to other cells in the body. The MHC is able to recognize these antigens and present them to the T-cells of the immune system, so that they can be recognized and destroyed by those cells.
HLA-W (MHC class I, W pseudogene) is a gene that is located on the MHC class I molecule. It encodes a protein known as W, which is a key component of the MHC class I molecule. The W protein plays a crucial role in the presentation of antigens to the immune system by interacting with the MHC class II molecules.
One of the functions of the W protein is to bind to the MHC class II molecules and help them to be processed and loaded onto the MHC class I molecules. This is important for presenting antigens from the body's own cells to the immune system. The W Protein is also involved in regulating the presentation of antigens from intracellular pathogens, such as viruses and bacteria, to the immune system.
Another function of the W protein is to help to ensure that the MHC class I molecules are properly processed and loaded onto the MHC class II molecules. This is important for presenting antigens from intracellular pathogens to the immune system. The W protein is also involved in regulates the presentation of antigens from cancer cells to the immune system.
HLA-W is also a potential drug target in cancer. cancer cells can use MHC class I molecules to present antigens to the immune system, which allows them to evade the immune response. By inhibiting the activity of W, researchers hope to be able to help to present antigens from cancer cells to the immune system, which could lead to the development of more effective cancer treatments.
In addition to its role in presenting antigens to the immune system, W is also involved in regulating the immune response. The W protein helps to ensure that the immune response is properly regulated, which is important for maintaining the body's overall health.
Overall, HLA-W (MHC class I, W pseudogene) is a gene that is important for the immune system's ability to recognize and destroy pathogens from the body. It is also involved in regulating the immune response, which is important for maintaining the body's overall health. As such, HLA-W is a potential drug target in cancer and other diseases.
Protein Name: Major Histocompatibility Complex, Class I, W (pseudogene)
More Common Targets
HLCS | HLF | HLTF | HLX | HM13 | HMBOX1 | HMBS | HMCES | HMCN1 | HMCN2 | HMG20A | HMG20B | HMGA1 | HMGA1P2 | HMGA1P4 | HMGA1P7 | HMGA1P8 | HMGA2 | HMGA2-AS1 | HMGB1 | HMGB1P1 | HMGB1P10 | HMGB1P19 | HMGB1P37 | HMGB1P38 | HMGB1P46 | HMGB1P5 | HMGB1P6 | HMGB2 | HMGB2P1 | HMGB3 | HMGB3P1 | HMGB3P14 | HMGB3P15 | HMGB3P19 | HMGB3P2 | HMGB3P22 | HMGB3P24 | HMGB3P27 | HMGB3P30 | HMGB3P6 | HMGB4 | HMGCL | HMGCLL1 | HMGCR | HMGCS1 | HMGCS2 | HMGN1 | HMGN1P16 | HMGN1P30 | HMGN1P37 | HMGN1P8 | HMGN2 | HMGN2P13 | HMGN2P15 | HMGN2P18 | HMGN2P19 | HMGN2P24 | HMGN2P25 | HMGN2P30 | HMGN2P38 | HMGN2P46 | HMGN2P5 | HMGN2P6 | HMGN2P7 | HMGN3 | HMGN3-AS1 | HMGN4 | HMGN5 | HMGXB3 | HMGXB4 | HMHB1 | HMMR | HMOX1 | HMOX2 | HMSD | HMX1 | HMX2 | HNF1A | HNF1A-AS1 | HNF1B | HNF4A | HNF4G | HNF4GP1 | HNMT | HNRNPA0 | HNRNPA1 | HNRNPA1L2 | HNRNPA1L3 | HNRNPA1P10 | HNRNPA1P12 | HNRNPA1P16 | HNRNPA1P2 | HNRNPA1P21 | HNRNPA1P27 | HNRNPA1P33 | HNRNPA1P35 | HNRNPA1P36 | HNRNPA1P39 | HNRNPA1P41